Evidence map›Paper›PMID 35501176›Full record

ReviewHematology/oncology clinics of North America2022

Screening for Colorectal Cancer.

Samir Gupta

Abstract readReview
In one paragraph

Review in Hematology/oncology clinics of North America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Samir GuptaGI Section, VA San Diego Healthcare System, Department of Gastroenterology, University of California San Diego, 3350 La Jolla Village Drive, MC 111D, San Diego, CA 92161, USA. Electronic address: s1gupta@health.ucsd.edu.

Funding

CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.UH3CA233314 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUPTA, SAMIR, HILL, LINDA L · 2020 to 2023
$4.9M
Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and MortalityR37CA222866 · NCI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GUPTA, SAMIR · 2018 to 2023
$3.3M
CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.UG3CA233314 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CASTANEDA, SHEILA FAYE, GUPTA, SAMIR · 2019 to 2019
$604k
HSRD VA I01 HX003605NCI NIH HHS R37 CA222866NCI NIH HHS UG3 CA233314NCI NIH HHS UH3 CA233314
6 · The paper itself

Abstract

Colorectal cancer (CRC) is the second-leading cause of cancer death in the United States. Screening reduces CRC incidence and mortality. 2021 US Preventive Service Task Force (USPSTF) guidelines and available evidence support routine screening from ages 45 to 75, and individualized consideration of screening ages 76 to 85. USPSTF guidelines recommend annual guaiac fecal occult blood testing, annual fecal immunochemical testing (FIT), annual to every 3-year multitarget stool DNA-FIT, every 5-year sigmoidoscopy, every 10-year sigmoidoscopy with annual FIT, every 5-year computed tomographic colonography, and every 10-year colonoscopy as options for screening. The "best test is the one that gets done."

Indexed as

Colorectal NeoplasmsEarly Detection of CancerAgedAged, 80 and overColonoscopyHumansMass ScreeningMiddle AgedOccult BloodSigmoidoscopyUnited StatesColorectal cancerEarly detectionIncidenceMortalityPreventionScreening

Identifiers

PMID35501176
PMCPMC9167799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.